IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 16 filers reported holding IMMUCELL CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 27 | -88.8% | 0.00% | – |
| Q2 2023 | $1,000 | – | 241 | +173.9% | 0.00% | – |
| Q3 2020 | $0 | – | 88 | +8700.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 1 | -99.8% | 0.00% | – |
| Q3 2017 | $3,000 | -25.0% | 501 | +0.2% | 0.00% | – |
| Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | -42.9% | 500 | -50.0% | 0.00% | – |
| Q2 2016 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERRITT CAPITAL MANAGEMENT INC | 154,300 | $1,285,000 | 0.38% |
| HEARTLAND ADVISORS INC | 199,600 | $1,663,000 | 0.11% |
| Minerva Advisors LLC | 14,559 | $121,000 | 0.06% |
| Essex Financial Services, Inc. | 23,776 | $198,000 | 0.04% |
| SHUFRO ROSE & CO LLC | 50,791 | $423,000 | 0.04% |
| INGALLS & SNYDER LLC | 91,511 | $762,000 | 0.03% |
| RBF Capital, LLC | 13,086 | $109,000 | 0.01% |
| FLAGSHIP HARBOR ADVISORS, LLC | 3,000 | $26,000 | 0.01% |
| Renaissance Technologies | 96,100 | $801,000 | 0.00% |
| MORGAN STANLEY | 11,732 | $98,000 | 0.00% |